Paul Schulz, MD
Behavioral Neurology & Neuropsychiatry · Houston, TXNPI 1184710477
Payments from drug & device makers
Across 1,362 payments — averaging $10,354 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$8.7M
- AbbVie$1.1M
- Novartis$1.1M
- Genentech, Inc.$790K
- UCB SA$693K
- Novo Nordisk AS$489K
- plus $1.2M from 12 others
Across 25 payments — averaging $2133.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$32K
- Acadia Pharmaceuticals Inc$11K
- Novo Nordisk AS$10K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 88 | $8,747,870 |
| AbbVie | 61 | $1,117,037 |
| Novartis | 5 | $1,107,319 |
| Genentech, Inc. | 38 | $790,160 |
| UCB SA | 11 | $692,540 |
| Novo Nordisk AS | 114 | $488,942 |
| Lilly USA, LLC | 267 | $267,250 |
| Acadia Pharmaceuticals Inc | 395 | $257,288 |
| Eisai Inc. | 277 | $242,586 |
| Alnylam Pharmaceuticals Inc. | 53 | $204,198 |
| Janssen Research & Development, LLC | 10 | $134,346 |
| Biogen | 36 | $49,834 |
| Merck | 1 | $2,558 |
| Amneal Pharmaceuticals LLC | 2 | $231 |
| Abbott | 1 | $196 |
| SK Life Science, Inc. | 1 | $125 |
| GE HealthCare | 1 | $33 |
| UCB, Inc. | 1 | $32 |
How this compares
Too few behavioral neurology & neuropsychiatry providers in Texasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other behavioral neurology & neuropsychiatry in Houston
- David HunterHouston$2.1M
- Ricardo JorgeHouston$1K
- Melissa JonesHouston$885
- Christopher MerklHouston$104
- Olga OchoaHouston$24
- Syed IqbalHouston$11
- John BertelsonAustin$669K
- Gabriel de ErausquinSan Antonio$357K
- Alicia ParkerSan Antonio$203K
- Hilary ButellaThe Woodlands$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.